Abbott Laboratories has issued software patches to some of its implantable cardiac devices (manufactured by St. Jude) for cybersecurity flaws and battery issues that have plagued the devices, necessitating the U.S. Food and Drug Administration (FDA) to previously issue warnings to patients about the devices [view related posts here and here].

There are more

The Food and Drug Administration (FDA) recently issued a warning letter to St. Jude Medical, alleging that it failed to properly investigate issues with the batteries in its defibrillator implants and for failing to fix the cybersecurity of its in-home monitoring system, known as Merlin@home. The monitoring system is wireless and is connected to St.